peptide science retatrutide | Research Peptide Vial Retatrutide 20mg Research Peptide |

Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns Drugs like Ozempic, Wegovy, Zepbound and Mounjaro have been around for years, but theyve recently been making headlines due to a rise in popularity as weight loss agents

In 2021, the FDA approved Novo Nordisk's Wegovy, a slight reformulation of Ozempic designed specifically for weight loss, which drove a huge spike in public awareness of GLP-1 agonists

Ascletis reported enhanced fat loss with ASC47 in semaglutide combo studies

2012;303:F96371

Gard Wellness offers comprehensive weight loss solutions and are here to help

Millions of members who had relied on medications like Wegovy, Zepbound, and Saxenda woke up to letters explaining that their weight loss medications would no longer be covered as of January 1, 2026